Form 6-K Valens Semiconductor For: May 19
- Wall Street mints big gains to end strong week
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
- U.S. Supreme Court overturns Roe v. Wade, ends constitutional right to abortion
- FedEx (FDX) Gains on Solid FY23 Outlook, Analysts Mostly Bulled Up Into Next Week's Investors Day
- Get Ready for a 10% Rally in S&P 500
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2022
Commission File Number: 001-40842
VALENS SEMICONDUCTOR LTD.
(Exact name of registrant as specified in its charter)
8 Hanagar St. POB 7152
Hod Hasharon 4501309
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|Form 20-F||☒||Form 40-F||☐|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
CEO AND DIRECTOR PURCHASING SHARES OF VALENS SEMICONDUCTOR STOCK
The information in this 6-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.
Valens Semiconductor Ltd. (the “Company”) (NYSE: VLN) announced today that on May 16, May 17, and May 18, 2022, Gideon Ben Zvi, Chief Executive Officer and a member of the Board of Directors of the Company, and Moshe Lichtman, a member of the Board of Directors of the Company, informed the Company that they had each purchased an aggregate amount of 27,900 of the Company’s ordinary shares, no par value, for a total aggregate amount of approximately US$100,000 by each.
Mr. Ben Zvi and Mr. Lichtman are not generally required to disclose to the market their plans to purchase or sell ordinary shares (other than in limited circumstances, including in the Company’s Annual Report on Form 20-F) and do not assume any obligation to disclose to the market additional purchases or sales, except where required by law.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|VALENS SEMICONDUCTOR LTD.|
|By:||/s/ Dror Heldenberg|
|Title:||Chief Financial Officer|
Date: May 19, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Velan Inc.: Announcement
- Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
- Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!